Form 8-K - Current report:
SEC Accession No. 0001493152-25-010138
Filing Date
2025-03-13
Accepted
2025-03-13 07:40:30
Documents
15
Period of Report
2025-03-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 40274
2 ex99-1.htm EX-99.1 93554
3 ex99-1_001.jpg GRAPHIC 4397
  Complete submission text file 0001493152-25-010138.txt   326822

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE indp-20250313.xsd EX-101.SCH 3021
5 XBRL LABEL FILE indp-20250313_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE indp-20250313_pre.xml EX-101.PRE 24169
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3579
Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 (646) 427-2727
Indaptus Therapeutics, Inc. (Filer) CIK: 0001857044 (see all company filings)

IRS No.: 863158720 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40652 | Film No.: 25733852
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)